Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

The Design and Fabrication of μCCA-μGI Device for Toxicity Evaluation of Acetaminophen

아세트아미노펜 독성평가를 위한 μCCA-μGI 디바이스의 개발

  • Chang Jung-Yun (Korea food and Drug Administration) ;
  • Shuler Michael L. (Cornell University)
  • Published : 2006.08.21
Download PDF
⟨ Previous Next ⟩

Abstract

Deficiencies in the early ADMET(absorption, distribution, metabolism, elimination and toxicity) information on drug candidate extract a significant economic penalty on pharmaceutical firms. Microscale cell culture analogue-microscale gastrointestinal(${\mu}CCA-{\mu}GI$) device using Caco 2, L2 and HEp G2/C3A cells, which mimic metabolic process after absorption occurring in humans was used to investigate the toxicity of the model chemical, acetaminophen(AAP). The toxicity of acetaminophen determined after induction of CYP 1A1/2 in Caco 2 cells was not significant. In a coculture system, although no significant reduction in viability of HEp G2/C3A and L2 cells was found, approximately 5 fold increase in the CYP 1A1/2 activity was observed. These results appear to be related to organ-organ interaction. The oral administration of a drug requires addition of the absorption process through small intestine to the current ${\mu}CCA$ device. Therefore, a perfusion coculture system was employed for the evaluation of the absolution across the small intestine and resulting toxicity in the liver and lung. This system give comprehensive and physiologic information on oral uptake and resulting toxicity as in the body. The current ${\mu}CCA$ device can be used to demonstrate the toxic effect due to organ to organ interaction after oral administration,

Keywords

References

  1. L.M. Sweeny, M.L. Shuler, J.G. Babish and A. Ghanem, A cell culture analogue of rodent physiology: application to naphthalene toxicology, Toxicol in Vitro., 59, 307-316 (1995)
  2. K. Viravaidya and M.L. Shuler, Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analogue device for toxicity studies, Biotechnol. Prog., 20, 590-597 (2004) https://doi.org/10.1021/bp034238d
  3. D.G. Davidson and W.N. Eastham, Acute liver necrosis following overdose of paracetamol, Br. Med. J., 5512, 497-499 (1966)
  4. J.R. Mitchell, Acetaminophen toxicity, N. Engl. J. Med., 31, 1601-1602 (1988)
  5. T. Ishida, M. Abe, K. Oguri and H. Yamada, Enhancement of acetaminophen cytotoxicity in selenium-binding protein-overexpressed COS-1 Cells, Drug Metab. Pharmacokin, 19, 290-296 (2004) https://doi.org/10.2133/dmpk.19.290
  6. J.D Gibson, N.R. Pumford, V.M. Samokyszyn and J.A. Hinson, Mechanism of acetaminophen-induced hepatotoxi-city: covalent binding versus oxidative stress, Chem. Res. Toxicol., 9, 580-585 (1996) https://doi.org/10.1021/tx950153d
  7. J.A. Brent and B.H. Rumack, Role of free radicals in toxic hepatic injury. II Are free radicals the cause of toxin-induced liver injury.? J. Toxicol. Clin. Toxicol., 31, 173-196 (1993) https://doi.org/10.3109/15563659309000384
  8. J. Liu, Y. Liu, D. Hartley, C.D. Klaassen, S.E. Shehin-Johnson, A. Lucas and S.D. Cohen, Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity, J. Pharmacol. Exp. Ther., 289, 580-586 (1999)
  9. S.H. Choi, M. Nishikawa, A. Sakoda and Y. Sakai, Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity, Toxicol. in Vitro., 18, 393-402 (2004) https://doi.org/10.1016/j.tiv.2003.09.010
  10. B. Davies and T. Morris, Physiological parameters in laboratory animals and humans, Pharm. Res., 7, 1093-1095 (1993)
  11. R.D. Kanter, M. Monshouwer, A.L. Draaisa, M.H. De Jager, I.A.M. De Graaf, J.H. Proost, D.K.F. Meijer and G.M.M. Groothuis, Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon, Xenobio., 24, 229-241 (2004)
  12. A. Sin, K.C. Chin, M.F. Jamil, Y. Kostov, G. Rao and M.L. Shuler, The design and fabrication of three chamber microscale cell culture analogue devices with integrated dissolved oxygen sensors, Biotechnol. Prog., 20, 338-345 (2004) https://doi.org/10.1021/bp034077d
  13. P.T. Manyike, E.D. Kharasch, T.F. Kalhorn and J.T. Salttery, Contribution of CYP 2E1 and CYP 3A to acetaminophen reactive metabolite formation, Clin. Pharm & Therapeu., 67, 275-282 (2000) https://doi.org/10.1067/mcp.2000.104736
  14. S.D. Nelson, Mechanism of the formation and disposition of reactive metabolites that can cause acute liver injury, Drug Met. Res., 27, 147-177 (1995) https://doi.org/10.3109/03602539509029821
  15. V. Carriere, J. Chambaz and M. Rousset, Intestinal response to xenobiotics, Toxicol. in Vitro., 15, 373-378 (2001) https://doi.org/10.1016/S0887-2333(01)00039-X
  16. D.W. Rosenberg and T. Leff, Regulation of cytochrome P450 in cultured human colonic cells, Arch. Biochem. Biophy., 300, 186-192 (1993) https://doi.org/10.1006/abbi.1993.1026
  17. J.M. Gearhart, G.W. Jepson, H.J. Clewell, M.E. Anderson and R.B. Conolly, Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetyl-cholinesterase by disodiumpropylfluorophosphate, Toxicol. Applied Pharm., 106, 295-310 (1990) https://doi.org/10.1016/0041-008X(90)90249-T
  18. S. Rendic and F.J. Dicarlo, Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors, Drug Metab. Rev., 29, 413-80 (1997) https://doi.org/10.3109/03602539709037591
  19. T. Prueksaritanout, L.M. Gorham, J.H. Hochman, L.O. Tran and K.P. Vyas, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines and in Caco-2 cells, Drug Metab. Dispos., 24, 634-642 (1996)